Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. currently manages 4 pending office actions within the Semiconductors, Circuits & Optics technology area. These matters are distributed among 4 distinct examiners, indicating that each application is being reviewed by a different individual. The prosecution is organized across 3 distinct art units, suggesting that the company's filings in the Semiconductors, Circuits & Optics sector are grouped into several technical sub-categories.
The busiest examiner for the portfolio is CERIONI, DANIEL LEE, who is responsible for 1 busiest examiner pending office action. This confirms that the workload is perfectly distributed, as each of the 4 distinct examiners is handling exactly one of the company's pending matters. No single examiner currently manages more than one of the 4 pending office actions in the Semiconductors, Circuits & Optics sector.
The use of 3 distinct art units for 4 pending office actions indicates a degree of technical focus within the Semiconductors, Circuits & Optics field. However, with 4 distinct examiners involved, the company must still account for a variety of examination styles. The presence of 4 distinct examiners for 4 pending office actions requires the company to maintain several simultaneous dialogues with the patent office while following the standards of 3 distinct art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (50%) |
| §101 + other | 1 (25%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CERIONI, DANIEL LEE | 1 | 64.5% | +28.0% |
| JACKSON, JORDAN L | 1 | 40.8% | +38.5% |
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
| EPPERT, LUCY CLARE | 1 | 60.0% | +31.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906213 | BLOOD PRESSURE PREDICTION METHOD AND DEVICE USING MULTIPLE DATA SOURCES | EPPERT, LUCY CLARE | 84d overdue |
| 18246449 | DRUG COATING, DRUG-COATED BALLOON AND PREPARATION METHOD THEREOF | BECKHARDT, LYNDSEY MARIE | 15d |
| 18710433 | BLOOD GLUCOSE PREDICTION METHOD AND DEVICE BASED ON OPTICAL SIGNAL FEATURES AND METABOLIC THERMAL FEATURES | CERIONI, DANIEL LEE | — |
| 18856545 | BLOOD GLUCOSE PREDICTION METHOD AND DEVICE COMBINING BIG DATA MODEL AND PERSONALIZED MODEL | JACKSON, JORDAN L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906213 | BLOOD PRESSURE PREDICTION METHOD AND DEVICE USING MULTIPLE DATA SOURCES | EPPERT, LUCY CLARE | 84d overdue |
| 18246449 | DRUG COATING, DRUG-COATED BALLOON AND PREPARATION METHOD THEREOF | BECKHARDT, LYNDSEY MARIE | 15d |
| 18710433 | BLOOD GLUCOSE PREDICTION METHOD AND DEVICE BASED ON OPTICAL SIGNAL FEATURES AND METABOLIC THERMAL FEATURES | CERIONI, DANIEL LEE | — |
| 18856545 | BLOOD GLUCOSE PREDICTION METHOD AND DEVICE COMBINING BIG DATA MODEL AND PERSONALIZED MODEL | JACKSON, JORDAN L | — |
| Art Unit | Apps |
|---|---|
| 2857 | 1 |
| 1613 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18710433 | BLOOD GLUCOSE PREDICTION METHOD AND DEVICE BASED ON OPTICAL SIGNAL FEATURES AND METABOLIC THERMAL FEATURES | CERIONI, DANIEL LEE | — | §101§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18856545 | BLOOD GLUCOSE PREDICTION METHOD AND DEVICE COMBINING BIG DATA MODEL AND PERSONALIZED MODEL | JACKSON, JORDAN L | 2857 | §101 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18246449 | DRUG COATING, DRUG-COATED BALLOON AND PREPARATION METHOD THEREOF | BECKHARDT, LYNDSEY MARIE | 1613 | §112 | Final Rejection | 15d | Pending | Mar 23, 2023 |
| 17906213 | BLOOD PRESSURE PREDICTION METHOD AND DEVICE USING MULTIPLE DATA SOURCES | EPPERT, LUCY CLARE | 3791 | §101 | Non-Final OA | 84d overdue | Pending | Sep 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial